Standard BioTools
LAB
LAB
79 hedge funds and large institutions have $291M invested in Standard BioTools in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 84 → 79 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
79
Holding in Top 10
1
Calls
$1.41M
Puts
$1.04M
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.69M | |
| 3 | +$939K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$912K |
| 5 |
Renaissance Technologies
New York
|
+$616K |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$910K | |
| 3 | -$410K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$339K |
| 5 |
BlackRock
New York
|
-$291K |